Dubois' lupus erythematosus and related syndromes /

Dubois' Lupus Erythematosus was first published in 1966. For the past forty years, the product has distinguished itself internationally as the go-to reference on lupus and related diseases For rheumatologists and internal medicine practitioners who need a comprehensive clinical reference on sys...

Full description

Bibliographic Details
Corporate Author:	ScienceDirect (Online service)
Other Authors:	Wallace, Daniel J. (Daniel Jeffrey), 1949-, Hahn, Bevra, Dubois, Edmund L.
Format:	eBook
Language:	English
Published:	Philadelphia, PA : Elsevier/Saunders, ©2013.
Edition:	8th ed.
Series:	ClinicalKey.
Subjects:	Systemic lupus erythematosus. Lupus erythematosus. Lupus Erythematosus, Cutaneous Lupus Erythematosus, Systemic Lupus érythémateux disséminé. Lupus érythémateux. HEALTH & FITNESS > Diseases > Musculoskeletal. MEDICAL > Orthopedics. MEDICAL > Rheumatology. Lupus erythematosus Systemic lupus erythematosus Electronic books.
Online Access:	Connect to the full text of this electronic book

Table of Contents:

Section I: What is lupus?
chapter 1. Definition and classification of lupus and lupus-related disorders / Jinoos Yazdany and Maria Dall'Era
chapter 2. The epidemiology of lupus / S. Sam Lim and Christina Drenkard.
Section II: The pathogenesis of lupus
chapter 3. The pathogenesis of SLE / Bevra H. Hahn
chapter 4. Genetics of human SLE / Yun Deng and Betty P. Tsao
chapter 5. Epigenetics of lupus / Nan Shen, Dong Liang, Yuajia Tang, and Yuting Qin
chapter 6. The innate immune system in SLE / Lukas Bossaller and Ann Marshak-Rothstein
chapter 7. Cytokines and interferons in lupus / Mary K. Crow, Timothy B. Niewold, and Kyriakos A. Kirou
chapter 8. The structure and derivation of antibodies and autoantibodies / Giovanni Franchin, Yong-Rui Zou, and Berry Diamond
chapter 9. T cells / José C. Crispin and George C. Tsokos
chapter 10. Regulatory cells in SLE / Antonio la Cava
chapter 11. Apoptosis, necrosis, and autophagy / Keith B. Elkon
chapter 12. Abnormalities in immune complex clearance and Fcy receptor function / Jane E. Salmon and Robert P. Kimberly
chapter 13. Neural-immune interactions: principles and relevance to SLE / Cherie L. Butts and Esther M. Sternberg
chapter 14. Complement and SLE / Chau-Ching Liu, Susan Manzi, and Joseph M. Ahearn
chapter 15. Mechanisms of acute inflammation and vascular injury in SLE / J. Michelle Kahlenberg and Mariana J. Kaplan
chapter 16. Mechanisms of tissue damage-free radicals and fibrosis / Biji T. Kurien, Chandra Mohan, and R. Hal Scofield
chapter 17. Animal models of SLE / Bevra Hannahs Hahn and Dwight Kono
chapter 18. Pathogenetic mechanisms in lupus nephritis / Anne Davidson, Celine Berthier, and Matthias Kretzler.
Section III: Autoantibodies
chapter 19. Immune tolerance defects in lupus / Ram Raj Singh, Shweta Dubey, and Julia Pinkhasov
chapter 20. Autoantibodies / edited by David Isenberg
Antibody structure, function, and production / Jessica Manson
Antibodies to DNA, histones, and nucleosomes / Anisur Rahman, Jessica Manson, and David Isenberg
Anti-lipoprotein and anti-endothelial cell antibodies / Anisur Rahman
Anti-C1q antibodies / C.G.M. Kallenberg
Antibodies against the extractable nuclear antigens RNP, Sm, Ro/SSA, and La/SSB / Gabriela Riemekasten and Falk Hiepe
chapter 21. Autoantigenesis and antigen-based therapy and vaccination in SLE / Ram Raj Singh, Julia Pinkhasov, Priti Prasad, and Shweta Dubey.
Section IV: Clinical aspects of SLE
chapter 22. Overview and clinical presentation / Andrea Hinojosa-Azaola and Jorge Sánchez-Guerrero
chapter 23. Pathomechanisms of cutaneous lupus erythematosus / Jan P. Dutz
chapter 24. Skin disease in cutaneous lupus erythematosus / Benjamin F. Chong and Victoria P. Werth
chapter 25. The musculoskeletal system and bone metabolism / Sandra V. Navarra and Tito P. Torralba
chapter 26. Pathogenesis and treatment of atherosclerosis in lupus / Maureen McMahon, Brian Skaggs, and Jennifer Grossman
chapter 27. Cardiopulmonary disease in SLE / Guillermo Ruiz-Irastorza and Munther Khamashta
chapter 28. Pathogenesis of the nervous system / Cynthia Aranow, Betty Diamond, and Meggan Mackay
chapter 29. Clinical aspects of the nervous system / Sterling G. West
chapter 30. Psychopathology, neurodiagnostic testing, and imaging / John G. Hanly, Antonina Omisade, and John D. Fisk
chapter 31. Ocular, aural, and oral manifestations / James T. Rosenbaum, Dennis R. Trune, Andre Barkhuizen, and Lyndell Lim
chapter 32. Management of Sjödren syndrome in patients with SLE / Hendrika Bootsma, Hjalmar R. Bouma, Frans G.M. Kroese, Arjan Vissink, and Daniel J. Wallace
chapter 33. Gastrointestinal and hepatic manifestations / David S. Hallegua and Swamy Venuturupalli
chapter 34. Hematologic and lymphoid abnormalities in SLE / George A. Karpouzas
chapter 35. Clinical and epidemiologic features of lupus nephritis / Mary Anne Dooley.
Section V: The reproductive system and hormones
chapter 36. Pregnancy in women with SLE / Megan E.B. Clowse
chapter 37. Neonatal lupus erythematosus / Marie Wahren-Herlenius, Sven-Erik Sonesson, and Megan E.G. Clowse
chapter 38. Reproductive and hormonal issues in women with autoimmune diseases / Eliza F. Chakravarty.
Section VI: Special considerations, subsets of SLE and lupus-related syndromes
chapter 39. Drug-induced lupus: etiology, pathogenesis, and clinical aspects / Dipak Patel and Bruce Richardson
chapter 40. SLE in childhood and adolescence / Thomas J.A. Lehman
chapter 41. Mixed connective tissue disease and undifferentiated connective tissue disease / Robert W. Hoffman and Eric L. Greidinger
chapter 42. Clinical aspects of the antiphospholipid syndrome / Aisha Lateef and MIchelle Petri.
Section VII: Assessment of lupus
chapter 43. Clinical application of serologic tests, serum protein abnormalities, and other clinical laboratory tests in SLE / Francisco P. Quismorio, Jr., and Karina D. Torralba
chapter 44. Differential diagnosis and disease associations / Meenakshi Jolly, Serene Francis, and Winston Sequeira
chapter 45. SLE and infections / Judith A. James, Andrea L. Sestak, and Evan S. Vista
chapter 46. Clinical measures, metrics, and indices / Zahi Touma, Dafna D. Gladman, and Murray B. Urowitz.
Section VIII: Managemen of SLE
chapter 47. Principles of therapy, local measures, and nonsteroidal medications / Mariko Ishimori, Michael H. Weisman, Katy Setoodeh, and Daniel J. Wallace
chapter 48. Systemic glucocorticoid therapy in SLE / Kyriakos A. Kirou and Dimitrios T. Boumpas
chapter 49. Antimalarial medications / J. Antonio Aviña-Zubieta and John M. Esdaile
chapter 50. Immunosuppressive drug therapy / W. Joseph McCune and Tania Gonzalez-Rivera
chapter 51. Specialized treatment approaches and niche therapies for lupus / Daniel J. Wallace
chapter 52. Adjunctive and preventive measures / Diane L. Kamen
chapter 53. Novel therapies for SLE: biological agents available in practice today / Ronald F. van Vollenhoven
chapter 54. Critical issues in drug development for SLE / Ronald F. van Vollenhoven
chapter 55. Socioeconomic and disability aspects / Michael M. Ward.
Section IX: Outcomes and future considerations
chapter 56. Investigational agents and future therapy for SLE / Georg H. Stummvoll and Josef S. Smolen
chapter 57. Mortality in SLE / Sasha Bernatsky, Deborah Levy, Rosalind Ramsey-Goldman, Caroline Gordon, Anisur Rahman, and Ann E. Clarke
Appendix: Lupus resource materials / Jenny Thorn Palter.